MeSH tree: C14.907.585.124
Cannabis use is linked to a doubling in the risk of dying from cardiovascular disease, with significantly heightened risks of having a stroke or acute coronary syndrome—sudden reduced or blocked blood flow to the heart—finds ...
Jun 17, 2025
0
50
People who sit or remain sedentary for more than 14 hours a day, on average, may have a higher risk of a cardiovascular event or death in the year after treatment at a hospital for symptoms of a heart attack such as chest ...
May 19, 2025
0
1
Researchers from the University of Tokyo have found a way to observe clotting activity in blood as it happens—without needing invasive procedures. Using a new type of microscope and artificial intelligence (AI), their study ...
May 15, 2025
0
2
Patients who were counseled on heart medications and lifestyle modifications by specially trained nurses were 30% less likely to experience cardiovascular death, heart attack or stroke five years after being hospitalized ...
Mar 31, 2025
0
0
After a cardiovascular event, it proves difficult to maintain a healthier, more active lifestyle over the long term. Although sedentary time decreases after participation in a cardiac rehabilitation lifestyle program, it ...
Mar 25, 2025
0
0
For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor monotherapy is associated with lower bleeding risk, without ...
Feb 19, 2025
0
0
Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with an increased CAD risk, according to a review published online Nov. 21 in the Journal of Clinical ...
Dec 22, 2024
0
0
A new study uncovers how the COVID-19 pandemic reshaped emergency care for acute coronary syndrome, with a sharp decline in hospital visits nationwide. Analyzing over 61,000 cases, the research reveals that older adults, ...
Dec 19, 2024
0
0
An investigation published in The BMJ raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the US and Brilique in Europe), ...
Dec 12, 2024
0
26
A new study assessing provincial and territorial variations in reimbursement criteria of drug coverage for patients covered by Canada's public pharmacare programs for two common cardiovascular conditions revealed significant ...
Dec 11, 2024
0
0
